In contrast, our study showed the significance of micro-EGFR T790M subclones in EGFR-TKI treatment, which reflect the efficacy of EGFR-TKI against T790M-positive cancer cells as previously demonstrated in a preclinical study12. Here, EGFR is linked to cancer.